Advanced Malignant Mesothelioma

14 clinical trials · Condition

Record	Firm	Date
HMPL-453 in Advanced Malignant Mesothelioma (NCT04290325)	Hutchison Medipharma Limited	2019-12-30
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (NCT01126346)	Wake Forest University Health Sciences	2010-05-01
AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma (NCT01105390)	National Cancer Institute (NCI)	2010-04-01
Pazopanib in Treating Patients With Malignant Pleural Mesothelioma (NCT00459862)	National Cancer Institute (NCI)	2007-03-01
Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma (NCT00392444)	National Cancer Institute (NCI)	2007-02-01
PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery (NCT00365053)	National Cancer Institute (NCI)	2006-06-01
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery (NCT00309946)	National Cancer Institute (NCI)	2005-12-01
Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung (NCT00039182)	National Cancer Institute (NCI)	2002-05-01
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498)	National Cancer Institute (NCI)	2001-12-01
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma (NCT00027703)	National Cancer Institute (NCI)	2001-10-01
EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer (NCT00028782)	National Cancer Institute (NCI)	2001-10-01
Gefitinib in Treating Patients With Malignant Mesothelioma (NCT00025207)	National Cancer Institute (NCI)	2001-09-01

Track Advanced Malignant Mesothelioma automatically

Every clearance here is in the API, with alerts when new ones post.